Juul Labs, partially owned by Altria (formerly Philip Morris), is accused of utilizing Big Tobacco's historical playbook to secure market dominance through state-level legislation. The company employs hundreds of lobbyists to push for state laws that preempt local city ordinances, effectively making it harder for independent vape shops to operate. This strategy aims to position Juul as the primary FDA-approved option while eliminating smaller competitors.
